MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Status of NPF-QII after six years: Updates to the dataset

    F. Cubillos, E.C. Nelson, T. Simuni, C. Marras, M. Rafferty, T. Davis, P. Schmidt (Miami, FL, USA)

    Objective: To describe the status and recent findings from the National Parkinson Foundation's Quality Improvement Initiative (NPF-QII), an 8,179 subject observational clinical study conducted at…
  • 2016 International Congress

    Neural plasticity and freezing of gait: Stepping through the FoG

    B.W. Fling, M. Mancini, P. Carlson-Kuhta, L.A. King, K. Smulders, D.S. Peterson, N. Pal, J.G. Nutt, F.B. Horak (Portland, OR, USA)

    Objective: 1) To determine the efficacy of our cognitively challenging Agility Boot Camp (ABC-C) rehabilitation intervention and 2) to evaluate neural mechanisms and plasticity within…
  • 2016 International Congress

    Classification and recommendation of nonpharmacological therapies for Parkinson’s disease

    T.T.C. Capato, C.H. Fen, E.R. Barbosa (São Paulo, Brazil)

    Objective: A multidisciplinary specialized treatment including physiotherapy, speech and language therapy, occupational therapy (OT) associated to the ideal pharmacological treatment and surgical is recommended to…
  • 2016 International Congress

    Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration

    A. Di Marco, G. Auciello, A. Vecchi, D. Vignone, M.R. Battista, E. Bracacel, F. Bonelli, E. Nizi, E. Monteagudo, M. Beconi (Pomezia, Italy)

    Objective: To establish a stable human neuronal model defective in PanK2. Background: Pantothenate Kinase-Associated Neurodegeneration (PKAN), is caused by mutations in PANK2, which encodes one…
  • 2016 International Congress

    Stereotactic pallidotomy for Parkinson’s disease in El Salvador: One year follow up

    S.L. Peña, R.E. Amaya (San Salvador, El Salvador)

    Objective: Characterize patients with idiopathic Parkinson's disease undergoing posteroventral pallidotomy. Assess improvement in motor symptoms after pallidotomy. Background: Parkinson's disease is a neurodegenerative disease with…
  • 2016 International Congress

    “Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia

    S. Sekimoto, G. Oyama, T. Jo, A. Nakajima, Y. Shimo, M. Nakajima, A. Umemura, M. Ito, H. Arai, N. Hattori (Bunkyo-ku, Japan)

    Objective: To describe a patient underwent deep brain stimulation (DBS) with different target in left and right. Background: DBS is a therapeutic option for movement…
  • 2016 International Congress

    Strengths and weaknesses of patient-reported outcomes following DBS surgery: Comparing clinician, patient, and caregiver assessments

    L. Shahgholi, W. Deeb, K. Foote, A. Shukla, U. Akbar, J.P. Rossi, S. De Jesus, M.S. Okun (Gainesville, FL, USA)

    Objective: Assess the degree of correlation between DBS outcome measures rated by patients, caregivers, and clinicians. Methods: The Clinician Global Impression (CGI) score and two…
  • 2016 International Congress

    The long-term follow-up of subthalamic nucleus deep brain stimulation comparing medication alone in advanced Parkinson’s disease patients

    S.H. Lin, S.Y. Chen, F.S. Jaw (Hualien, Taiwan)

    Objective: To investigate whether advanced Parkinson's disease (PD) patients receive subthalamic nucleus deep brain stimulation (STN-DBS) or medical treatment alone have different long-term outcome. Background:…
  • 2016 International Congress

    Pisa syndrome in Parkinson’s disease effectively treated with subthalmic deep brain stimulation: Case report

    C.A. Artusi, A. Romagnolo, M. Zibetti, M.G. Rizzone, A. Merola, F. Dematteis, M. Lanotte, L. Lopiano (Torino, Italy)

    Objective: To report the case of a 67-year-old Parkinsonian patient with significant and disabling Pisa syndrome (PS) successfully treated with subthalamic nucleus deep brain stimulation…
  • 2016 International Congress

    Jaw opening dystonia and blepharospasm following bilateral VIM DBS for postural and action dystonic tremor

    V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, B. Cheeran, T. Lynch (Dublin, Ireland)

    Objective: We report an elderly patient with jaw opening dystonia and blepharospasm post-bilateral thalamic DBS performed for atypical dystonic tremor. Background: Ventral intermediate nucleus (VIM)…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley